Literature DB >> 20600940

Human papillomavirus-like particles vaccine efficiently produced in a non-fermentative system based on insect larva.

Alicia Fernández-San Millán1, Silvia Gómez-Sebastián, María C Nuñez, Jon Veramendi, José M Escribano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600940     DOI: 10.1016/j.pep.2010.06.009

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


× No keyword cloud information.
  5 in total

1.  Comparison of strategies for the production of FMDV empty capsids using the baculovirus vector system.

Authors:  V Ruiz; A C Mignaqui; M C Nuñez; E Reytor; J M Escribano; A Wigdorovitz
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

Review 2.  New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention.

Authors:  Elizabeth D Gersch; Lutz Gissmann; Robert L Garcea
Journal:  Antivir Ther       Date:  2011-11-07

3.  Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.

Authors:  Felicitat Todolí; Alhelí Rodríguez-Cortés; María Del Carmen Núñez; Márcia D Laurenti; Silvia Gómez-Sebastián; Fernando Rodríguez; Eva Pérez-Martín; José M Escribano; Jordi Alberola
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

4.  A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae.

Authors:  Yang Wu; Liangyu Jiang; Hao Geng; Tian Yang; Zengpeng Han; Xiaobing He; Kunzhang Lin; Fuqiang Xu
Journal:  Mol Ther Methods Clin Dev       Date:  2018-07-04       Impact factor: 6.698

5.  Rotavirus A-specific single-domain antibodies produced in baculovirus-infected insect larvae are protective in vivo.

Authors:  Silvia Gómez-Sebastián; Maria C Nuñez; Lorena Garaicoechea; Carmen Alvarado; Marina Mozgovoj; Rodrigo Lasa; Alan Kahl; Andres Wigdorovitz; Viviana Parreño; José M Escribano
Journal:  BMC Biotechnol       Date:  2012-09-07       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.